Previous Section
Drug Therapy
1. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms.
- Author
- Wassef R; Haenold R; Hansel A; Brot N; Heinemann SH; Hoshi T;
- Institution
- Department of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Journal
- J Neurosci. 2007 Nov 21;27(47):12808-16.
- Abstract URL
- Click here to view abstract
2. Impact of pramipexole on the onset of levodopa-related dyskinesias.
- Author
- Constantinescu R; Romer M; McDermott MP; Kamp C; Kieburtz K;
- Institution
- Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.
- Journal
- Mov Disord. 2007 May 29;.
- Abstract URL
- Click here to view abstract
3. Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off.
- Author
- Deuschl G; Vaitkus A; Fox GC; Roscher T; Schremmer D; Gordin A;
- Institution
- Department of Neurology, Christian-Albrechts-Universitat, Kiel, Germany.
- Journal
- Mov Disord. 2007 May 21;.
- Abstract URL
- Click here to view abstract
4. Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.
- Author
- de Bie RM; Miyasaki J; Lang AE; Fox SH;
- Institution
- Movement Disorders Centre, Division of Neurology University of Toronto, Toronto, Ontario, Canada.
- Journal
- Can J Neurol Sci. 2007 Nov;34(4):438-42.
- Abstract URL
- Click here to view abstract
5. Coaxil (tianeptine) in the treatment of depression in Parkinson's disease.
- Author
- Levin OS;
- Institution
- Department of Neurology, Russian Medical Academy of Postgraduate Education, Russia.
- Journal
- Neurosci Behav Physiol. 2007 May;37(4):419-24.
- Abstract URL
- Click here to view abstract
6. Advances in the Pharmacologic Management of Early Parkinson Disease.
- Author
- Hauser RA; Zesiewicz TA;
- Institution
- From the *Department of Neurology and daggerParkinson's Disease and Movement Disorders Center, University of South Florida and Tampa General Healthcare, Tampa, Florida; double daggerDepartments of Neurology, Pharmacology and Experimental Therapeutics; and the section signNational Parkinson Foundation Center of Excellence.
- Journal
- Neurologist. 2007 May;13(3):126-132.
- Abstract URL
- Click here to view abstract
7. Levodopa raises objective pain threshold in Parkinson's disease: A RIII reflex study.
- Author
- Gerdelat-Mas A; Simonetta-Moreau M; Thalamas C; Ory-Magne F; Slaoui T; Rascol O; Brefel-Courbon C;
- Institution
- Hopital Purpan, France.
- Journal
- J Neurol Neurosurg Psychiatry. 2007 May 15;.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
